Nathan J Dowden - Net Worth and Insider Trading
Nathan J Dowden Net Worth
The estimated net worth of Nathan J Dowden is at least $2 Million dollars as of 2024-05-03. Nathan J Dowden is the President & COO of Entrada Therapeutics Inc and owns about 137,204 shares of Entrada Therapeutics Inc (TRDA) stock worth over $2 Million. Details can be seen in Nathan J Dowden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nathan J Dowden has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).
Transaction Summary of Nathan J Dowden
Nathan J Dowden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathan J Dowden owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of Nathan J Dowden’s form 4 insider trades.
Insider Ownership Summary of Nathan J Dowden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-03-06 | Chief Operating Officer |
Nathan J Dowden Latest Holdings Summary
Nathan J Dowden currently owns a total of 1 stock. Nathan J Dowden owns 137,204 shares of Entrada Therapeutics Inc (TRDA) as of March 6, 2024, with a value of $2 Million.
Latest Holdings of Nathan J Dowden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-03-06 | 137,204 | 13.53 | 1,856,370 |
Holding Weightings of Nathan J Dowden
Nathan J Dowden Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathan J Dowden has made a total of 12 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 1,826 shares on March 6, 2024, which brought Nathan J Dowden around $22,496.
Insider Trading History of Nathan J Dowden
- 1
Nathan J Dowden Trading Performance
Nathan J Dowden Ownership Network
Nathan J Dowden Owned Company Details
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Nathan J Dowden is the Chief Operating Officer of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Financial Officer Kory James Wentworth , director & President and CEO Dipal Doshi , and Chief Medical Officer Nerissa Kreher .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Nathan J Dowden made 4 insider transaction in Entrada Therapeutics Inc (TRDA) with a net sale of 25,877. Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 34,092 shares made by Dipal Doshi , a net sale of 52,896 shares made by Kory James Wentworth , and a net purchase of 15,892 shares made by Peter S Kim .
In summary, during the past 3 months, insiders sold 6,912 shares of Entrada Therapeutics Inc (TRDA) in total and bought 15,892 shares, with a net purchase of 8,980 shares. During the past 18 months, 167,506 shares of Entrada Therapeutics Inc (TRDA) were sold and 15,892 shares were bought by its insiders, resulting in a net sale of 151,614 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
Nathan J Dowden Mailing Address
Above is the net worth, insider trading, and ownership report for Nathan J Dowden. You might contact Nathan J Dowden via mailing address: 6 Tide Street, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
